Publications by authors named "Steven D Schutt"

Claim this Profile
T
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease.
Steven D Schutt, Yongxia Wu, Arjun Kharel, David Bastian, Hee-Jin Choi

J Clin Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay.
Hee-Jin Choi, Chih-Hang Anthony Tang, Linlu Tian, Yongxia Wu, M Hanief Sofi, Steven D Schutt

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
Hung Nguyen, Ali Alawieh, David Bastian, Sandeepkumar Kuril, Min Dai, Steven D Schutt

Clin Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.
M Hanief Sofi, Yongxia Wu, Steven D Schutt, Min Dai, Anusara Daenthanasanmak

J Clin Invest· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.
Steven D Schutt, Yongxia Wu, Chih-Hang Anthony Tang, David Bastian, Hung Nguyen

Blood Adv· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice.
Steven D Schutt, Jianing Fu, Hung Nguyen, David Bastian, Jessica Heinrichs

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis